The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
CD8 T Cells Utilize TRAIL to Control Influenza Virus Infection
Open accessAbstract
Elimination of influenza virus-infected cells during primary influenza virus infections is thought to be mediated by CD8+ T cells though perforin- and FasL-mediated mechanisms. However, recent studies suggest that CD8+ T cells can also utilize TRAIL to kill virally infected cells. Therefore, we herein examined the importance of TRAIL to influenza-specific CD8+ T cell immunity and to the control of influenza virus infections. Our results show that TRAIL deficiency increases influenza-associated morbidity and influenza virus titers, and that these changes in disease severity are coupled to decreased influenza-specific CD8+ T cell cytotoxicity in TRAIL−/− mice, a decrease that occurs despite equivalent numbers of pulmonary influenza-specific CD8+ T cells. Furthermore, TRAIL expression occurs selectively on influenza-specific CD8+ T cells, and high TRAIL receptor (DR5) expression occurs selectively on influenza virus-infected pulmonary epithelial cells. Finally, we show that adoptive transfer of TRAIL+/+ but not TRAIL−/− CD8+ effector T cells alters the mortality associated with lethal dose influenza virus infections. Collectively, our results suggest that TRAIL is an important component of immunity to influenza infections and that TRAIL deficiency decreases CD8+ T cell-mediated cytotoxicity, leading to more severe influenza infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus
Kash, J. C., Tumpey, T. M., Proll, S. C., Carter, V., Perwitasari, O., Thomas, M. J., Basler, C. F., Palese, P., Taubenberger, J. K., García-Sastre, A., et al. (2006) · Nature · doi:10.1038/nature05181 · Cited by 551
Dynamic programming of CD8+ T lymphocyte responses
van Stipdonk, M. J. B., Hardenberg, G., Bijker, M. S., Lemmens, E. E., Droin, N. M., Green, D. R., & Schoenberger, S. P. (2003) · Nature Immunology · doi:10.1038/ni912 · Cited by 401
T Cell Responses to Influenza Virus Infection: Effector and Memory Cells
Swain, S. L., Dutton, R. W., & Woodland, D. L. (2004) · Viral Immunology · doi:10.1089/0882824041310577 · Cited by 63
Research works printed but not linked: 42
- 1984, In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific, 814
- 1996, Cytotoxic T cell effector and memory function in viral immunity, 1
- 1997, CD8+ T cells clear influenza virus by perforin or Fas-dependent processes, 5197
- 1998, Mechanism of protective immunity against influenza virus infection in mice without antibodies, 322
- 1998, Clearance of an influenza A virus by CD4+ T cells is inefficient in the absence of B cells, 882
- 2007, Heterogeneity of effector phenotype for acute phase and memory influenza A virus-specific CTL, 64
- 2004, Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity, 2418
- 1996, Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family, 12687
- 2001, Production of interferon-γ by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology, 119
- 2003, Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand, 9156
- 1999, IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression, 920
- 2001, Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l, 11128
- 2005, Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs, 425
- 2002, Characterization of the in vivo function of TNF-α-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice, 2246
- 2005, DR5 knockout mice are compromised in radiation-induced apoptosis, 2000
- 2003, Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection, 265
- 2005, Lymph node dendritic cells control CD8+ T cell responses through regulated FasL expression, 649
- 2000, A previously unrecognized H-2Db-restricted peptide prominent in the primary influenza A virus-specific CD8+ T-cell response is much less apparent following secondary challenge, 3486
- 2005, Vaccination with an acidic polymerase epitope of influenza virus elicits a potent antiviral T cell response but delayed clearance of an influenza virus challenge, 696
- 2006, A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies, 994
- 2005, Histone deacetylase inhibitors modulate renal cell carcinoma sensitivity to TRAIL/Apo-2L-induced apoptosis by enhancing TRAIL-R2 expression, 1104
- 2004, Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection, 1209
- 2004, Receptor for advanced glycation end-products is a marker of type I lung alveolar cells, 165
- 1996, Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes, 5555
- 1998, Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells, 1492
- 2000, Early programming of T cell populations responding to bacterial infection, 6833
- 2001, The CD8 response on autopilot, 381
- 2006, Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells, 248
- 2007, Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage, 667
- 2005, Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice, 7658
- 2005, Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection, 5332
- 2002, TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections, 659
- 2000, Measles virus induces functional TRAIL production by human dendritic cells, 556
- 2001, Antiviral response by natural killer cells through TRAIL gene induction by IFN-α/β, 3138
- 2008, Cutting edge: Engagement of NKG2A on CD8+ effector T cells limits immunopathology in influenza pneumonia, 25
- 2000, Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans, 6105
- 1995, Interferons, Mx genes, and resistance to influenza virus, S67
- 2007, Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo, 9790
- 2003, Plasmacytoid dendritic cell-derived IFN-α induces TNF-related apoptosis-inducing ligand/Apo-2L-mediated antitumor activity by human monocytes following CpG oligodeoxynucleotide stimulation, 212
- 2006, TRAIL expression up-regulated by interferon-γ via phosphorylation of STAT1 induces myeloma cell death, 4115
- 1999, Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL, 1343
- 2005, Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104, 359
Cited by
Influenza virus-induced lung injury: pathogenesis and implications for treatment
Herold, S., Becker, C., Ridge, K. M., & Budinger, G. R. S. (2015) · European Respiratory Journal · doi:10.1183/09031936.00186214 · Cited by 503
Brandes, M., Klauschen, F., Kuchen, S., & Germain, R. N. (2013) · Cell · doi:10.1016/j.cell.2013.06.013 · Cited by 381
The CD8 T Cell Response to Respiratory Virus Infections
Schmidt, M. E., & Varga, S. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00678 · Cited by 371
Regulating the adaptive immune response to respiratory virus infection
Braciale, T. J., Sun, J., & Kim, T. S. (2012) · Nature Reviews Immunology · doi:10.1038/nri3166 · Cited by 361
Following TRAIL’s path in the immune system
Falschlehner, C., Schaefer, U., & Walczak, H. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03058.x · Cited by 299
Metadata
- Authors
- Brincks, E. L., Katewa, A., Kucaba, T. A., Griffith, T. S., & Legge, K. L.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-10-01
- Volume
- 181
- Issue
- 7
- Pages
- 4918-4925
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2139759276
- Cited by
- 199
- References
- 3
- FWCI
- 7.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.